Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations

Front Pharmacol. 2023 Mar 29:14:1180487. doi: 10.3389/fphar.2023.1180487. eCollection 2023.

George P Patrinos^{1

2

3}, Luis Abel Quinones^{4

5}, Chonlaphat Sukasem^{6

7}

¹ Laboratory of Pharmacogenomics and Individualized Therapy, Department of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece.
² Department of Genetics and Genomics, College of Medicine and Health Sciences, United Arab Emirates University, Al-Ain, United Arab Emirates.
³ United Arab Emirates University, Zayed Center for Health Sciences, Al-Ain, United Arab Emirates.
⁴ Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
⁵ Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain.
⁶ Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
⁷ Pharmacogenomics and Precision Medicine Clinic, Bumrungrad Genomic Medicine Institute (BGMI), Bumrungrad International Hospital, Bangkok, Thailand.

No abstract available

Keywords: genetics; personalized medicine; pharmacogenetics; pharmacogenomics; population.

Publication types